AU3068099A - Chromosome 11-linked coronary heart disease susceptibility gene chd1 - Google Patents

Chromosome 11-linked coronary heart disease susceptibility gene chd1

Info

Publication number
AU3068099A
AU3068099A AU30680/99A AU3068099A AU3068099A AU 3068099 A AU3068099 A AU 3068099A AU 30680/99 A AU30680/99 A AU 30680/99A AU 3068099 A AU3068099 A AU 3068099A AU 3068099 A AU3068099 A AU 3068099A
Authority
AU
Australia
Prior art keywords
chd1
chromosome
linked
heart disease
coronary heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30680/99A
Inventor
Dennis G. Ballinger
Wei Ding
Mark A. Hess
Susanne Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Myriad Genetics Inc
Original Assignee
Myriad Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myriad Genetics Inc filed Critical Myriad Genetics Inc
Publication of AU3068099A publication Critical patent/AU3068099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU30680/99A 1998-03-04 1999-03-04 Chromosome 11-linked coronary heart disease susceptibility gene chd1 Abandoned AU3068099A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3494198A 1998-03-04 1998-03-04
US09034941 1998-03-04
US8093498P 1998-04-06 1998-04-06
US60080934 1998-04-06
PCT/US1999/004682 WO1999045112A2 (en) 1998-03-04 1999-03-04 Chromosome 11-linked coronary heart disease susceptibility gene chd1

Publications (1)

Publication Number Publication Date
AU3068099A true AU3068099A (en) 1999-09-20

Family

ID=26711582

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30680/99A Abandoned AU3068099A (en) 1998-03-04 1999-03-04 Chromosome 11-linked coronary heart disease susceptibility gene chd1

Country Status (2)

Country Link
AU (1) AU3068099A (en)
WO (1) WO1999045112A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104050344A (en) * 2013-09-30 2014-09-17 西安时代基因健康科技有限公司 Method for acquiring characterization parameters of coronary disease
CN116144753A (en) * 2022-12-27 2023-05-23 湖南家辉生物技术有限公司 Application and detection reagent of pathogenic gene CHD1 mutation site

Also Published As

Publication number Publication date
WO1999045112A2 (en) 1999-09-10
WO1999045112A3 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
AU2974200A (en) Cardiac constraint jacket construction
GB0026498D0 (en) Bioinformatic transaction scheme
AU7680300A (en) Human dna sequences
AU6418498A (en) Human genes
AU1344400A (en) Inflammation-associated genes
AU3479700A (en) Genes associated with diseases of the colon
EP1077996A4 (en) HUMAN EDG3sb GENE
AU6257298A (en) Breast cancer specific gene 1
AU1020201A (en) Human sphingosine kinase gene
IL142895A0 (en) Adenine nucleotide translocator polyptides
AUPQ262599A0 (en) Gene expression
HUP0105208A3 (en) Gene therapy-1
AU3068099A (en) Chromosome 11-linked coronary heart disease susceptibility gene chd1
IL146332A0 (en) PrP-LIKE GENE
AU1812801A (en) Short shared nucleotide sequences
AU7983298A (en) Disease related nucleotide kinases
AU1541399A (en) Human nucleotide pyrophosphohydrolase-2
AU7064500A (en) Human narcolepsy gene
AU1773501A (en) Human single nucleotide polymorphisms
GB9924981D0 (en) Gene therapy
AU4577099A (en) Human fast-1 gene
AU2470101A (en) Genetic sequences associated with neural cell proliferation and disease
AU3099200A (en) Novel human wnt gene
GB9900009D0 (en) Gene therapy
AU3269401A (en) Simultaneous hybridization/priming for snp analysis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase